1-20 of 73
Ignacio I. Wistuba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC

Pedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, Alberto Cruz-Bermúdez, Neus Bota-Rabassedas, Beatriz Sanchez-Espiridon, Katsuhiro Yoshimura, Carmen Behrens, Wei Lu, Ximing Tang, Apar Pataer, Edwin R. Parra, Cara Haymaker, Junya Fujimoto, Stephen G. Swisher, John V. Heymach, Don L. Gibbons, J. Jack Lee, Boris Sepesi, Tina Cascone, Luisa M. Solis, Mariano Provencio, Ignacio I. Wistuba, Humam Kadara
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2461–2473.
https://doi.org/10.1158/1078-0432.CCR-21-3207
Published: 01 June 2022
View article titled, Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC
Open the PDF for Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC in another window
Includes: Supplementary data
Journal Articles

Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception

Sharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, Ximing Tang, Yu Shen, Wei Qiao, Mei Jiang, Shanyu Zhang, Barbara Mino, Wei Lu, Renganayaki Pandurengan, Cara Haymaker, Kajsa Affolter, Courtney L. Scaife, Michele Yip-Schneider, C. Max Schmidt, Matthew A. Firpo, Sean J. Mulvihill, Eugene J. Koay, Huamin Wang, Ignacio I. Wistuba, Anirban Maitra, Luisa M. Solis, Subrata Sen
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1938–1947.
https://doi.org/10.1158/1078-0432.CCR-21-2585
Published: 02 May 2022
View article titled, Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception
Open the PDF for Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception in another window
Includes: Supplementary data
Journal Articles

Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy

Marta Casarrubios, Alberto Cruz-Bermúdez, Ernest Nadal, Amelia Insa, María del Rosario García Campelo, Martín Lázaro, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martínez-Martí, Javier de Castro-Carpeño, Manuel Cobo, Guillermo López-Vivanco, Edel Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Miguel Barquín, Raquel Laza-Briviesca, Belén Sierra-Rodero, Edwin R. Parra, Beatriz Sanchez-Espiridion, Pedro Rocha, Humam Kadara, Ignacio I. Wistuba, Atocha Romero, Virginia Calvo, Mariano Provencio
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (21): 5878–5890.
https://doi.org/10.1158/1078-0432.CCR-21-1200
Published: 01 November 2021
View article titled, Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy
Open the PDF for Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy in another window
Journal Articles

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinton Yam, Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Jr, Gheath Alatrash, Haven Garber, Lei Huo, Fei Yang, Anne V. Philips, Qing-Qing Ding, Bora Lim, Naoto T. Ueno, Kasthuri Kannan, Xiangjie Sun, Baohua Sun, Edwin Roger Parra Cuentas, William Fraser Symmans, Jason B. White, Elizabeth Ravenberg, Sahil Seth, Jennifer L. Guerriero, Gaiane M. Rauch, Senthil Damodaran, Jennifer K. Litton, Jennifer A. Wargo, Gabriel N. Hortobagyi, Andrew Futreal, Ignacio I. Wistuba, Ryan Sun, Stacy L. Moulder, Elizabeth A. Mittendorf
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (19): 5365–5375.
https://doi.org/10.1158/1078-0432.CCR-21-0144
Published: 01 October 2021
View article titled, Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer
Open the PDF for Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)

Helen X. Chen, Minkyung Song, Holden T. Maecker, Sacha Gnjatic, David Patton, J. Jack Lee, Stacey J. Adam, Radim Moravec, Xiaole Shirley Liu, Ethan Cerami, James Lindsay, Ming Tang, F. Stephen Hodi, Catherine J. Wu, Ignacio I. Wistuba, Gheath Al-Atrash, Chantale Bernatchez, Sean C. Bendall, Stephen M. Hewitt, Elad Sharon, Howard Streicher, Rebecca A. Enos, Melissa D. Bowman, Valerie M. Tatard-Leitman, Beatriz Sanchez-Espiridion, Srinika Ranasinghe, Mina Pichavant, Diane M. Del Valle, Joyce Yu, Sylvie Janssens, Jenny Peterson-Klaus, Cathy Rowe, Gerold Bongers, Robert R. Jenq, Chia-Chi Chang, Jeffrey S. Abrams, Margaret Mooney, James H. Doroshow, Lyndsay N. Harris, Magdalena Thurin
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (18): 5038–5048.
https://doi.org/10.1158/1078-0432.CCR-20-3241
Published: 15 September 2021
View article titled, Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Open the PDF for Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC) in another window
Journal Articles

Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC

Bita Sahaf, Mina Pichavant, Brian H. Lee, Caroline Duault, Emily M. Thrash, Melanie Davila, Nicolas Fernandez, Karen Millerchip, Salah-Eddine Bentebibel, Cara Haymaker, Natalia Sigal, Diane M. Del Valle, Srinika Ranasinghe, Sarah Fayle, Beatriz Sanchez-Espiridion, Jiexin Zhang, Chantale Bernatchez, Catherine J. Wu, Ignacio I. Wistuba, Seunghee Kim-Schulze, Sacha Gnjatic, Sean C. Bendall, Minkyung Song, Magdalena Thurin, J. Jack Lee, Holden T. Maecker, Adeeb Rahman
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5062–5071.
https://doi.org/10.1158/1078-0432.CCR-21-2052
Published: 15 September 2021
View article titled, Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC
Open the PDF for Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC in another window
Journal Articles

Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network

Guray Akturk, Edwin R. Parra, Evisa Gjini, Ana Lako, J. Jack Lee, Donna Neuberg, Jiexin Zhang, Shen Yao, Ilaria Laface, Anita Rogic, Pei-Hsuan Chen, Beatriz Sanchez-Espiridion, Diane M. Del Valle, Radim Moravec, Robert Kinders, Courtney Hudgens, Catherine Wu, Ignacio I. Wistuba, Magdalena Thurin, Stephen M. Hewitt, Scott Rodig, Sacha Gnjatic, Michael T. Tetzlaff
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5072–5083.
https://doi.org/10.1158/1078-0432.CCR-21-2051
Published: 15 September 2021
View article titled, Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
Open the PDF for Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network in another window
Journal Articles

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

Apostolia M. Tsimberidou, Philip A. Beer, Carrie A. Cartwright, Cara Haymaker, Henry H. Vo, Simin Kiany, Alexander R.L. Cecil, James Dow, Kemal Haque, Franck A. Silva, Lucy Coe, Helen Berryman, Elisabeth A. Bone, Graciela M. Nogueras-Gonzalez, David Vining, Hilary McElwaine-Johnn, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3584–3594.
https://doi.org/10.1158/1078-0432.CCR-21-0238
Published: 01 July 2021
View article titled, Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
Open the PDF for Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases

Preeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, Young Uk Kim, Rossana Lazcano, Swati Gite, Daniele Lorenzini, Ignacio I. Wistuba, Rebecca S. Slack Tidwell, Xiaofei Song, Wai Chin Foo, Dipen M. Maru, Yun Shin Chun, Andy Futreal, Bryan Kee, David Menter, Luisa Solis, Ching-Wei Tzeng, Christine Parseghian, Kanwal Raghav, Van Morris, Chia-Chi Chang, Robert Jenq, Alda Tam, Chantale Bernatchez, Scott Kopetz, Jean-Nicolas Vauthey, Michael J. Overman
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (11): 3039–3049.
https://doi.org/10.1158/1078-0432.CCR-21-0163
Published: 01 June 2021
View article titled, Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases
Open the PDF for Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases in another window
Includes: Supplementary data
Journal Articles

Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

Jeffrey S. Morris, Rajyalakshmi Luthra, Yusha Liu, Dzifa Y. Duose, Wonyul Lee, Neelima G. Reddy, Justin Windham, Huiqin Chen, Zhimin Tong, Baili Zhang, Wei Wei, Manyam Ganiraju, Bradley M. Broom, Hector A. Alvarez, Alicia Mejia, Omkara Veeranki, Mark J. Routbort, Van K. Morris, Michael J. Overman, David Menter, Riham Katkhuda, Ignacio I. Wistuba, Jennifer S. Davis, Scott Kopetz, Dipen M. Maru
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (1): 120–130.
https://doi.org/10.1158/1078-0432.CCR-20-2403
Published: 04 January 2021
View article titled, Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting
Open the PDF for Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting in another window
Includes: Supplementary data
Journal Articles

Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment

Runzhe Chen, Won-Chul Lee, Junya Fujimoto, Jun Li, Xin Hu, Reza Mehran, David Rice, Stephen G. Swisher, Boris Sepesi, Hai T. Tran, Chi-Wan Chow, Latasha D. Little, Curtis Gumbs, Cara Haymaker, John V. Heymach, Ignacio I. Wistuba, J. Jack Lee, P. Andrew Futreal, Jianhua Zhang, Alexandre Reuben, Anne S. Tsao, Jianjun Zhang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (20): 5477–5486.
https://doi.org/10.1158/1078-0432.CCR-20-1767
Published: 15 October 2020
View article titled, Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Open the PDF for Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment in another window
Includes: Supplementary data
Journal Articles

Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic

Heather A. Lankes, Mark A. Watson, Richard C. Jordan, Nilsa C. Ramirez, Ignacio I. Wistuba, Lois Shepherd, Irina A. Lubensky, Hala Makhlouf
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18_Supplement): PO-065.
https://doi.org/10.1158/1557-3265.COVID-19-PO-065
Published: 15 September 2020
View article titled, Abstract PO-065: National Clinical Trials Network biobanking during the COVID-19 pandemic
Journal Articles

A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer

Tina Cascone, Boris Sepesi, Heather Y. Lin, Neda Kalhor, Edwin R. Parra, Mei Jiang, Myrna C.B. Godoy, Jianjun Zhang, Frank V. Fossella, Anne S. Tsao, Vincent K. Lam, Charles Lu, Frank E. Mott, George R. Simon, Mara B. Antonoff, Reza J. Mehran, David C. Rice, Carmen Behrens, Annikka Weissferdt, Cesar Moran, Ara A. Vaporciyan, J. Jack Lee, Stephen G. Swisher, Don L. Gibbons, Ignacio I. Wistuba, William N. William, Jr., John V. Heymach
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (14): 3525–3536.
https://doi.org/10.1158/1078-0432.CCR-19-4180
Published: 15 July 2020
View article titled, A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer
Open the PDF for A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

Feng Xie, Jianjun Zhang, Jiayin Wang, Alexandre Reuben, Wei Xu, Xin Yi, Frederick S. Varn, Yongsheng Ye, Junwen Cheng, Miao Yu, Yue Wang, Yufeng Liu, Mingchao Xie, Peng Du, Ke Ma, Xin Ma, Penghui Zhou, Shengli Yang, Yaobing Chen, Guoping Wang, Xuefeng Xia, Zhongxing Liao, John V. Heymach, Ignacio I. Wistuba, P. Andrew Futreal, Kai Ye, Chao Cheng, Tian Xia
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 2908–2920.
https://doi.org/10.1158/1078-0432.CCR-19-1744
Published: 15 June 2020
View article titled, Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy
Open the PDF for Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy in another window
Includes: Supplementary data
Journal Articles

The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma

Minglei Zhuo, Yanfang Guan, Xue Yang, Lingzhi Hong, Yuqi Wang, Zhongwu Li, Runzhe Chen, Hussein A. Abbas, Lianpeng Chang, Yuhua Gong, Nan Wu, Jia Zhong, Wenting Chen, Hanxiao Chen, Zhi Dong, Xiang Zhu, Jianjie Li, Yuyan Wang, Tongtong An, Meina Wu, Ziping Wang, Jiayin Wang, Emily B. Roarty, Waree Rinsurongkawong, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, John V. Heymach, Ignacio I. Wistuba, Neda Kalhor, Ling Yang, Xin Yi, P. Andrew Futreal, Bonnie S. Glisson, Xuefeng Xia, Jianjun Zhang, Jun Zhao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (4): 892–901.
https://doi.org/10.1158/1078-0432.CCR-19-0556
Published: 14 February 2020
View article titled, The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
Open the PDF for The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma in another window
Includes: Supplementary data
Journal Articles

Characterization and Comparison of GITR Expression in Solid Tumors

Luis Vence, Samantha L. Bucktrout, Irina Fernandez Curbelo, Jorge Blando, Bevin M. Smith, Ashley E. Mahne, John C. Lin, Terrence Park, Edward Pascua, Tao Sai, Javier Chaparro-Riggers, Sumit K. Subudhi, Jorge B. Scutti, Maria G. Higa, Hao Zhao, Shalini S. Yadav, Anirban Maitra, Ignacio I. Wistuba, James P. Allison, Padmanee Sharma
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6501–6510.
https://doi.org/10.1158/1078-0432.CCR-19-0289
Published: 01 November 2019
View article titled, Characterization and Comparison of GITR Expression in Solid Tumors
Open the PDF for Characterization and Comparison of GITR Expression in Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer

Yang Xie, Wei Lu, Shidan Wang, Ximing Tang, Hao Tang, Yunyun Zhou, Cesar Moran, Carmen Behrens, Jack A. Roth, Qinghua Zhou, David H. Johnson, Stephen G. Swisher, John V. Heymach, Vassiliki A. Papadimitrakopoulou, Guanghua Xiao, John D. Minna, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 150–157.
https://doi.org/10.1158/1078-0432.CCR-17-2543
Published: 03 January 2019
View article titled, Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
Open the PDF for Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract IA12: Developing precision medicine-based new lung cancer therapeutics

John D. Minna, Elizabeth McMillan, Luc Girard, Michael Peyton, Kenneth Huffman, Dhruba Deb, Paul Yenerall, Amit Das, Longshan Li, Maithili Dalvi, Boning Gao, Yang Xie, Yonghao Yu, Suzie Hight, Rachel Vaden, Caroline Diep, Michael Roth, Bruce Posner, John MacMillan, Ralph Deberardinis, David Wheeler, John V. Heymach, Ignacio I. Wistuba, Adi Gazdar, Michael White
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (17_Supplement): IA12.
https://doi.org/10.1158/1557-3265.AACRIASLC18-IA12
Published: 01 September 2018
View article titled, Abstract IA12: Developing precision medicine-based new lung cancer therapeutics
Journal Articles

The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2)

Dara L. Aisner, Lynette M. Sholl, Lynne D. Berry, Michael R. Rossi, Heidi Chen, Junya Fujimoto, Andre L. Moreira, Suresh S. Ramalingam, Liza C. Villaruz, Gregory A. Otterson, Eric Haura, Katerina Politi, Bonnie Glisson, Jeremy Cetnar, Edward B. Garon, Joan Schiller, Saiama N. Waqar, Lecia V. Sequist, Julie Brahmer, Yu Shyr, Kelly Kugler, Ignacio I. Wistuba, Bruce E. Johnson, John D. Minna, Mark G. Kris, Paul A. Bunn, David J. Kwiatkowski
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (5): 1038–1047.
https://doi.org/10.1158/1078-0432.CCR-17-2289
Published: 28 February 2018
View article titled, The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2)
Open the PDF for The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2) in another window
Includes: Supplementary data
Journal Articles

RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non–small Cell Lung Cancer

Yifan Wang, Jayanthi Gudikote, Uma Giri, Jun Yan, Weiye Deng, Rui Ye, Wen Jiang, Nan Li, Brian P. Hobbs, Jing Wang, Stephen G. Swisher, Junya Fujimoto, Ignacio I. Wistuba, Ritsuko Komaki, John V. Heymach, Steven H. Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2): 341–350.
https://doi.org/10.1158/1078-0432.CCR-17-1455
Published: 15 January 2018
View article titled, RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non–small Cell Lung Cancer
Open the PDF for RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non–small Cell Lung Cancer in another window
Includes: Supplementary data